BioMerieux : First-Half 2023 Results -Today at 02:42 am

bioMérieux - First-Half 2023 Results



€1,770 million in first-half 2023 sales, up 8.3% like-for-like; organic growth excluding...

Related Keywords

Suzhou ,Jiangsu ,China ,Salt Lake City ,Utah ,United States ,Turkey ,France ,India ,Turkish ,Chinese ,Asia Pacific ,Pierre Boulud ,Innorth America ,Jennifer Zinn ,Lab Efficiency ,For Panel ,Clinical Laboratory Improvement Amendments ,Drug Administration ,R Panel Mini ,Chief Executive Officer ,Latin America ,Biofire Defense ,Including Europe ,Middle East ,North America ,Executive Vice President ,Executive Chairman ,Chief Executive ,Executive Committee ,Chief Operating ,Clinical Operations ,Respiratory Syncytial Virus ,Markets ,